PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Driving instructors struggle to acquire new pupils regularly themselves so they pay substantial amounts to franchises such as RED and AA for regular pupils.
These franchises are expensive and inefficient but instructors have little choice. Our disruptive proposition offers all the benefits of a franchise in addition to new core features exclusive to Lessons Per Hour such as having a choice of pupils, exact travel distance and guaranteed payment from pupils before initial driving lessons.
days to go:
Expired
investment:
£7,448
Centaur Robotics is redefining mobility for the 10% of the global population who require assistance to walk 400 meters. Representing a £7 billion global opportunity, the company offers a blend of convenient service and innovative two-wheeled vehicle design, catering to individuals and collaborating with international brands in sectors such as airlines, shopping centers, retirement living, hotels, and restaurants.
After a successful 2020 investment round, Centaur Robotics is currently seeking the final £65,000 of its seed equity round. This funding will facilitate pre-production market trials, design refinements, large-scale testing, and production expansion. With established commercial traction, the company aims for a full commercial launch by June 2024.
days to go:
Expired
investment:
£795,101
Kolanot flex shipping portal is an AI-enabled platform for container shipment price comparison, booking and tracking. The company aims to provide the holy grail of door-to-door container shipping experience to customers without any intermediary.
days to go:
Expired
investment:
£40,680
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
A taxi and on-demand delivery service using electronically assisted, high-tech cargo bikes to offer a cleaner, faster and cheaper means of transportation. Pedal Me uses highly trained riders within London to carry almost any load, including two adults, which can all be booked through their app.
Between October 2017 and September 2018, Pedal Me generated revenues of more than £125k. They will be allocating investments towards increasing efficiency and improving pickup times.
Funds in this round will be used to add more bikes, riders and use smarter technology. Pedal Me aims to have more than 30 bikes within a 3-mile radius from the city centre. This will result in reducing pickup times to less than 8 minutes from a booking being placed. In addition, the company will 'stack' delivery jobs, which means one rider will be able to carry out multiple orders in a single journey and will therefore allow Pedal Me to keep prices down for customers. Future plans include expanding the service to the rest of the UK and overseas.
days to go:
Expired
investment:
£352,580
Rabble is a gamified and licensed fitness program that transforms exercise into fun, team-based games. It was first formed by a former international athlete and then financed by investors from the LA Fitness & Liverpool football club. Rabble has quickly risen to 100 authorized sites strengthening many healthy communities over the UK. It is a differentiated concept which is named as Global Fitness Trend (WGSN). It has a proven and scalable model where the market leaders earn revenue of more than $100m. Further, it has developed 100+ instructors across the UK in less than one year. Rabble aims at helping and changing more lives with the finance that it raises. It is planning to grow to more than 300 Rabble sites in the coming year.
days to go:
Expired
investment:
£274,530
